Ignite Creation Date:
2025-12-24 @ 7:00 PM
Ignite Modification Date:
2026-05-12 @ 3:48 PM
Study NCT ID:
NCT05110157
Status:
COMPLETED
Last Update Posted:
2025-07-10
First Post:
2021-10-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia
Sponsor:
Neurocrine Biosciences
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NBI-98854-ATS3019
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None